Drugs Controller General Of India
India  /  Published 26.04.22

Covaxin nod for kids aged 6-12

India's drug regulator has granted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the...
By Our Bureau, Agencies in New Delhi

India  /  Published 22.04.22

Plan to clear jab for 5-11 kids

Chennai: The Tamil Nadu government will grant 270 days’ leave to women employees and teachers to care for their children got through surrogacy. PTI ...
By PTI in New Delhi

Opinion  /  Published 11.04.22

Head: Letters to the Editor: How Bengalis have 'adopted' the once exotic 'phulkopi'

Flower power Sir — There will be few Bengalis who can imagine their lives without the cauliflower. Be it in machher jhol or shingara, the phulkopi is an inseparable pa...
By The Telegraph

India  /  Published 06.03.22

Covovax: Govt proposes consent for phase-3

An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on ...
By Our Bureau, PTI in New Delhi

West Bengal  /  Published 25.11.21

Needle-free ZyCov-D in Covid battle soon

After Covaxin, Covishield and Sputnik V, a fourth vaccine, DNA-based vaccine ZyCov-D is likely to be in use from next month in Bengal. The Union health ministry assured the state on Wednesday that it...
By Snehamoy Chakraborty in Bolpur(Birbhum)


India  /  Published 15.11.21

SII to export 5 crore jabs

  The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approve...
By Payal Banerjee in New Delhi

India  /  Published 12.10.21

Covaxin gets expert panel nod for 2 to 18 age group

An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain cond...
By Our Bureau, PTI in New Delhi

India  /  Published 05.10.21

Cadila: Nod for Covid jab trial

Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting phase III trials for its two-dose COVID-19 vaccine ZyCoV-D. The company has alread...
By Our Bureau, PTI in New Delhi

India  /  Published 21.08.21

Vaccine: Nod to jab for 12-plus kids

India has approved a DNA vaccine against Covid-19 developed by the Ahmedabad-based pharmaceutical company Zydus Cadila, the country’s second homegrown vaccine against the infection and the first...
By G.S. Mudur in New Delhi

India  /  Published 11.07.21

India's vaccine drive not as bad as it looks

First the good news – and then a host of qualifications. India’s vaccination drive’s been a jerky stop-and-start affair but it’s closer to its targets than might have been expe...
By Paran Balakrishnan in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.